InMed & UBC: Producing Cannabinoids in Labs
Learn more about InMed Pharma
InMed is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed’s proprietary bioinformatics database drug/disease targeting tool, cannabinoid biosynthesis technology and drug development pipeline are the fundamental value drivers of the Company.
For more information on InMed Pharmaceuticals (IN:TSX,IMLFF:OTCQX) please fill out the form below